ABOUT US
Cognifisense was founded by Tassilo Baeuerle, a serial tech entrepreneur, and Harald Stock, who was CEO of a world-leading pain pharmaceutical company. Their vision to combine deep neuroscience and immersive technologies to address maladaptive changes in the brain attracted thought leaders across neuroscience, psychology and pain therapeutics to the team.
Amanda Way was brought in as CEO in September 2024 to lead CognifiSense as it launches its first commercial product. VRNT (Virtual Reality Neuropsychological Therapy) is a patented, FDA cleared therapy for chronic lower back pain.
Compliance
CognifiSense is committed to complying with federal regulations on financial conflicts of interest in PHS- and NIH-funded research. Visit the link below to review our current Financial Conflict of Interest (FCOI) Policy: Financial Conflict of Interest Policy
Information concerning identified FCOIs held by senior/key personnel will be made available to requestors via email within five business days. This information may be requested by emailing us.